Raised serum S100B protein levels in neuropsychiatric lupus - Schenatto, C B; Xavier, R M; Bredemeier, M; Portela, L V C; Tort, A B L; Dedavid e Silva, T L; Souza, D O; Brenol, J C T (Annals of the rheumatic diseases, 2006)
Keywords: Adult; Antibodies; Antibodies, Anticardiolipin - blood; Antibodies, Antinuclear - blood; BDI; Beck Depression Inventory; Biological and medical sciences; Biomarkers - blood; Case-Control Studies; Cerebrovascular disease; Concise Report; confidence interval; Dermatology; Diseases of the osteoarticular system; Female; HCPA; Hospital de Clínicas de Porto Alegre; Humans; interquartile range; IQR; Lupus; Lupus Coagulation Inhibitor - blood; Lupus Erythematosus, Systemic - blood; Lupus Vasculitis, Central Nervous System - blood; Lupus Vasculitis, Central Nervous System - diagnosis; Male; Medical sciences; Middle Aged; Mini-Mental State Examination; MMSE; Nerve Growth Factors - blood; Nervous system; neuropsychiatric systemic lupus erythematosus; NPSLE; Prospective Studies; Proteins; Psychosis; Rheumatology; ROC Curve; S100 Calcium Binding Protein beta Subunit; S100 Proteins - blood; S100B protein; Sensitivity and Specificity; Skin involvement in other diseases. Miscellaneous. General aspects; SLE; SLEDAI; systemic lupus erythematosus; Systemic Lupus Erythematosus Disease Activity Index; Lupus; Serum; Skin disease; Protein; Rheumatology